|
Video: What is a Stock Split?
|
|
Strata Skin Sciences is a medical technology company in dermatology. Co. is engaged in developing, commercializing and marketing products for the treatment of dermatologic conditions. Co.'s products include the XTRAC® and Pharos® excimer lasers and VTRAC® lamp systems utilized in the treatment of psoriasis, vitiligo and various other skin conditions, as well as the TheraClear® X Acne Therapy System utilized in the treatment of acne-related skin conditions. The XTRAC and Pharos excimer laser technology emits ultraviolet light targeted primarily towards autoimmune dermatological skin disorders such as psoriasis, vitiligo, atopic dermatitis, and eczema, among others. According to our SSKN split history records, Strata Skin Sciences has had 1 split. | |
|
Strata Skin Sciences (SSKN) has 1 split in our SSKN split history database. The split for SSKN took place on April 07, 2017. This was a 1 for 5 reverse split, meaning for each 5 shares of SSKN owned pre-split, the shareholder now owned 1 share. For example, a 1000 share position pre-split, became a 200 share position following the split.
When a company such as Strata Skin Sciences conducts a reverse share split, it is usually because shares have fallen to a lower per-share pricepoint than the company would like. This can be important because, for example, certain types of mutual funds might have a limit governing which stocks they may buy, based upon per-share price. The $5 and $10 pricepoints tend to be important in this regard. Stock exchanges also tend to look at per-share price, setting a lower limit for listing eligibility. So when a company does a reverse split, it is looking mathematically at the market capitalization before and after the reverse split takes place, and concluding that if the market capitilization remains stable, the reduced share count should result in a higher price per share.
Looking at the SSKN split history from start to finish, an original position size of 1000 shares would have turned into 200 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into Strata Skin Sciences shares, starting with a $10,000 purchase of SSKN, presented on a split-history-adjusted basis factoring in the complete SSKN split history.
Growth of $10,000.00
Without Dividends Reinvested
|
Start date: |
04/28/2014 |
|
End date: |
04/24/2024 |
|
Start price/share: |
$2.65 |
|
End price/share: |
$0.56 |
|
Dividends collected/share: |
$0.00 |
|
Total return: |
-78.87% |
|
Average Annual Total Return: |
-14.40% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$2,113.11 |
|
Years: |
10.00 |
|
|
|
Date |
Ratio |
04/07/2017 | 1 for 5 |
|
|